Lilac Software

Name: Lilac Software
Brand: Lilac Software

AI Native

A modern, cloud native Payer Analytics Stack to drive better business & health outcomes

Est 2023|Raised $30K

LinkedIn 2K|Website|FTEs 6|HQ New York, New York, US

MarketsBusiness Intelligence (BI) and Analytics

Published Oct 13, 2026

01Common complaints

- You require a large volume of independently verified third-party reviews as a procurement requirement; public review footprint appears limited. - You need transparent, self-serve pricing and immediate purchase without enterprise contracting. - You have minimal internal data engineering capacity and expect a fully plug-and-play solution across many heterogeneous sources. - You require a mature vendor with a long public operating history and extensive customer references; Lilac’s publicly visible profile is relatively recent and was subject to acquisition. - You need non-U.S. payer support; product materials are focused on U.S. MA and CMS-related use cases.

Deal disqualifiers

Requirement for extensive, publicly available technical and security documentation
Need for abundant third-party reviews as procurement gating criteria
Small plans with limited analytics budgets for enterprise solutions

Vendor-acknowledged limitations

No explicit public "known issues" page or dated public roadmap commitments were found in retrieved sources.

Key limitations identified from available evidence

Limited public technical documentation (APIs, data model, supported connectors, SLAs).
Security details are high-level: SOC 2 Type II is claimed, but the SOC 2 report scope and findings are not publicly available.
Minimal independent review footprint, making it difficult to validate implementation effort, performance, and support quality.
Post-acquisition uncertainty (March 2026) regarding product packaging, roadmap, and long-term branding.

02Why they buy

Claimed differentiators (vendor-positioned)

Cloud-based payer analytics stack that aggregates and harmonizes payer data.
Analytics and operational workflows focused on MA Stars and quality performance.
Vendor describes AI features intended to support outreach and workflow automation; public technical substantiation is limited.

Differentiation supported by external sources (limited)

Inclusion on an NCQA vendor list indicates the vendor has engaged with industry measure certification processes.
Public claim of SOC 2 Type II compliance is documented on the vendor site.

Where competitors may have an advantage

Larger incumbents often provide broader packaged content libraries, more extensive integrations, longer track records, and more visible customer references.
Suites such as HealthEdge, Optum, and Inovalon may reduce vendor proliferation for organizations that prefer a single-vendor approach.

03Field reports

Major limitation: lack of mainstream review coverage

Searches across common B2B review platforms (G2, TrustRadius, Gartner Peer Insights) did not return a clearly attributable product review page for Lilac Software (the vendor's public website). Search results frequently returned unrelated companies using the Lilac name.

Community / social proof

Direct end-user commentary about Lilac Software (payer analytics) is scarce in public communities. This limited visibility is consistent with enterprise payer tooling, where public user reviews and forum posts are less common due to PHI and contracting norms. What was found: - A vendor announcement on a professional social platform claiming SOC 2 Type II certification (vendor announcement rather than independent user feedback). - Vendor-published content on an industry blog and the vendor’s site.

Vendor case studies / outcomes

Lilac publishes analyses and infographics about MA Stars trends; these materials are vendor-produced and do not include independently verified customer ROI metrics.

Balanced assessment (based on available evidence)

Because independent third-party reviews are minimal or absent in accessible sources:

Positive signals: public claims of SOC 2 Type II certification; acquisition by Medisolv; inclusion on an NCQA vendor list.
Negative/unknown signals: inability to validate customer satisfaction via independent reviews; limited publicly available technical and security documentation; pricing and contract terms are not publicly disclosed.

Public case studies found

No named customer case studies with independently verifiable ROI metrics were identified in publicly available sources.

Vendor-published data artifacts (not customer ROI)

Vendor-published MA Stars trend analyses and an infographic summarizing recent multi-year changes.

Critical evaluation: these materials provide market analysis but do not demonstrate client-level outcomes attributable to Lilac’s product.

04Best fit

Company size

Likely best fit:

Mid-sized to large Medicare Advantage plans where Stars and quality bonus economics justify investment.
Provider or ACO organizations could be addressed through Medisolv distribution channels post-acquisition.

Industries / verticals

Medicare Advantage
Managed Medicaid (depending on measures/state programs)
Value-based care organizations requiring claims and clinical quality intelligence

Roles and personas

VP/Director of Quality (Stars/HEDIS)
Payer analytics and data engineering leaders
Population health and care management operations
Compliance and regulatory reporting teams
CIO / CISO / vendor risk management for PHI and contractual reviews

Great-fit qualification criteria

Need to improve Stars performance and operationalize interventions
Fragmented data environment with long analytics lead times
Willingness to adopt cloud-based tooling and standardize data feeds

05The pitch

What the product does (core value proposition)

A cloud-based payer analytics platform that ingests and harmonizes claims, clinical, and operational data for U.S. health plans, with emphasis on Medicare Advantage (MA) use cases such as Stars and quality performance, compliance reporting, encounter data, risk adjustment, medical economics, and provider performance/price transparency analytics. Lilac’s public materials reference AI-based capabilities intended to support workflow automation and outreach related to quality measures; however, public documentation provides limited detail on specific AI functionality, model governance, and operational boundaries. Important naming caveat: “Lilac” is a common brand name across unrelated companies. This report covers Lilac Software (the vendor’s official website) (payer analytics) only.

Target market and positioning

Primary buyers: Medicare Advantage plans and other payer organizations; secondary buyers include organizations participating in value-based care that require claims-based quality measurement and outreach tooling.
Positioning: vendor describes a cloud-based analytics stack with data harmonization and claims a SOC 2 Type II certification.

Get a comprehensive analysis of Lilac Software including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →